Advertisement

 

 

Prophylaxis of vertical HBV infection.

Prophylaxis of vertical HBV infection.
Author Information (click to view)

Pawlowska M, Pniewska A, Pilarczyk M, Kozielewicz D, Domagalski K,


Pawlowska M, Pniewska A, Pilarczyk M, Kozielewicz D, Domagalski K, (click to view)

Pawlowska M, Pniewska A, Pilarczyk M, Kozielewicz D, Domagalski K,

Advertisement
Share on FacebookTweet about this on TwitterShare on LinkedIn

Expert opinion on drug safety 2016 7 21() 1-8

Abstract
INTRODUCTION
An appropriate management of HBV infection is the best strategy to finally reduce the total burden of HBV infection. Mother-to-child transmission (MTCT) is responsible for more than one third of chronic HBV infections worldwide. Because HBV infection in infancy or early childhood often leads to chronic infection, appropriate prophylaxis and management of HBV in pregnancy is crucial to prevent MTCT.

AREAS COVERED
The prevention of HBV vertical transmission is a complex task and includes: universal HBV screening of pregnant women, administration of antivirals in the third trimester of pregnancy in women with high viral load and passive-active HBV immunoprophylaxis with hepatitis B vaccine and hepatitis B immune globulin in newborns of all HBV infected women.

EXPERT OPINION
Universal screening of pregnant women for HBV infection, early identification of HBV DNA level in HBV-infected mothers, maternal treatment with class B according to FDA antivirals and passive/active anti-HBV immunoprophylaxis to newborns of HBV-positive mothers are crucial strategies for reducing vertical HBV transmission rates. Consideration of caesarean section in order to reduce the risk of vertical HBV transmission should be recommend in HBV infected pregnant women with high viral load despite antiviral therapy or when the therapy in the third trimester of pregnancy is not available.

Submit a Comment

Your email address will not be published. Required fields are marked *

three × four =

[ HIDE/SHOW ]